Quebec SEAO #20180445

Santé Québec seeks Medtronic EVOLUT FX and EVOLUT FX+ valves and related TAVI/TAVR supplies

Santé Québec Nord-de-l'Île-de-Montréal – Universitaire is seeking Medtronic valve products and related supplies for TAVI/TAVR procedures. - Government buyer: Santé Québec, Nord-de-l'Île-de-Montréal – Universitaire. - OEM and intended supplier: Medtronic is the valve OEM; Medtronic Canada is named as the intended supplier. - Products requested: Medtronic EVOLUT FX and EVOLUT FX+ percutaneous valves, plus associated accessories and consumables for transcatheter aortic valve replacement (TAVI/TAVR). Quantities and part numbers are not specified. - Notable requirements: The notice says Medtronic Canada is the only supplier able to meet the organization’s clinical, technical, and operational needs. It highlights the valves’ self-expanding, supra-annular design and clinical benefits for certain patient profiles. - Performance period: 36 months, with two one-year renewal options, for a possible total of 60 months. Specific start and end dates are not provided. - Estimated value: Not disclosed.

Description

The requirement is for the acquisition of Medtronic EVOLUT FX and EVOLUT FX+ percutaneous valves, along with the accessories and consumables needed for transcatheter aortic valve replacement (TAVI/TAVR) procedures. The notice intends to award the contract to Medtronic Canada, which the procuring organization says is the only supplier able to meet its clinical, technical, and operational needs. The contract is for 36 months, with two one-year renewal options, for a possible total duration of 60 months. The notice states that the estimated value is not disclosed.

View original listing